Your institution may have access to this item. Find your institution then sign in to continue.
Title
Trial watch.
Abstract
The article presents research highlights from the field of cancer research. Rafael Rosell et al. deal with personalized drug treatments in the article "Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression." In their research article, Shuta Tomida et al. outline their development of a relapse-related signature (RRS-82) for lung adenocarcinoma patients.